uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Lagevrio
Application withdrawn
Human
Details
EMA number
EMEA/H/C/005789
ATC code
J05A
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of coronavirus disease 2019 (COVID-19).
MeSH:
COVID-19 virus infection
Group:
Antivirals for systemic use
Active substances
molnupiravir
Marketing Authorisation Holder
Merck Sharp & Dohme B.V.
MAH
Lagevrio | uMedical